1199NBF
AETNA
AFFINITY HEALTH PLAN
BEECH STREET
CIGNA HMO
CIGNA PPO
EMPIRE BLUE CROSS HMO
EMPIRE BLUE CROSS OTHER PLANS
EMPIRE BLUE CROSS PPO
EMPIRE BLUE CROSS SENIOR PLAN
FIDELIS CARE NEW YORK
GHI CBP
GHI HMO
HEALTHFIRST
HIP
ISLAND GROUP ADMINISTRATION
MAGNACARE
MEDICAID
MEDICARE
MULTIPLAN
MULTIPLAN PHCS
MULTIPLAN SAVILITY
NEIGHBORHOOD HEALTH PLAN
NO FAULT
SUFFOLK HEALTH PLAN
UNITED EMPIRE PLAN (NYSHIP)
UNITED HEALTHCARE
UNITED OXFORD FREEDOM PLAN
VYTRA (except SMART START)
WORKERS COMP
Education & Training
Medical Degree:
Baylor College of Medicine, TX (1982)
Residency:
Internal Medicine, Baylor College of Medicine, TX
Fellowship:
Cardiovascular Disease, Cardiovascular Research Institute, University of California, San Francisco
Cardiology, University of California, San Francisco
Interventional Cardiology, Cleveland Clinic Foundation, OH
Hematology, University of California, San Francisco
Academic & Other
Academic Rank:
Professor
Teaching Activity:
Cardiovascular Medicine
Year Appointed at Stony Brook:
2004
Selected for inclusion in New York Magazine's Best Doctors 2010 listing
Editorial Board Member: American Journal of Cardiology, 2009
Editor-in-Chief, Heart International
Research
Outcomes research in cardiovascular disease
Diagnosis and treatment of the vulnerable plaque
Volume-Outcome Relationship
An Evaluation of the Oral Inflammatory Burden of Accute Coronary Syndrome Patients
African American Cardiac Patient Navigators To Improve Care Transition
INTERNAL MEDICINE
26 RESEARCH WAY,
EAST SETAUKET,
NY 11733-3453.
Ph.: 631-444-0580
Fax: 631-444-0562
INTERNAL MEDICINE
3001 EXPRESSWAY DRIVE NORTH,
SUITE 200 B,
ISLANDIA,
NY 11749-5301.
Ph.: 631-444-9600
Fax: 631-444-9621
Selected Publications
1. Berger JS, Vakili BA, Slater JN, Sherman W, Green SJ, Sanborn TA, Brown DL. Impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes and long-term survival following percutaneous coronary rotational atherectomy. J Throm Thrombolysis 2005;19:47-54.
2. Moscucci M, Eagle KA, Share D, Smith D, DeFranco AC, O'Donnell M, Kline-Rogers E, Jani SM, Brown DL. Public reporting and case selection for percutaneous coronary interventions. J Am Coll Cardiol. 2005;45:1759-1765.
3. R Andraws, JS Berger, DL Brown. Effects of antibiotic therapy on outcomes of patients with coronary artery disease: A meta-analysis of randomized controlled trials. JAMA.2005;293:2641-2647.
5. Kaplan RC, Bhalodkar NC, Brown EJ, White J, Brown DL. Race, ethnicity, and sociocultural characteristics predict noncompliance with lipid-lowering medications. Preventive Medicine 2004; 39:1249-1255.
6. Berger JS, Vakili BA, Sherman W, Sanborn TA, Brown DL. Influence of race on long-term survival following percutaneous coronary intervention. Am J Cardiol 2004; 94:647-649.
7. DL Brown (Editor), Cardiovascular Plaque Rupture, New York, Marcel Dekker, 2002.
8. DL Brown (Editor), Textbook of Cardiac Intensive Care, Philadelphia, W.B. Saunders Company, 1998.
Personal Statement
My practice philosophy is that by providing the highest quality, state-of-the-art care, patient outcomes will be enhanced.